Wegovy Cost in 2026: What You'll Actually Pay

Wegovy Cost in 2026: What You’ll Actually Pay

TL;DR:
- Wegovy’s high list price is rarely paid; most patients benefit from insurance or savings programs that lower costs significantly.
- Patients can reduce their expenses further by confirming coverage, registering for savings offers, and comparing prices through NovoCare and pharmacies.
Wegovy’s official list price is set high, but almost no one pays that. With commercial insurance and the Wegovy Savings Offer, many patients pay much less per month. Without insurance, the oral pill starts at a lower cost through NovoCare, and the injectable version is more expensive through the same program. Medicare Part D beneficiaries have a separate path: the Medicare GLP-1 Bridge offers all Wegovy doses at a reduced monthly cost during a limited period from mid-2026 through the end of 2027.
Your three fastest moves to lower what you pay:
- Call your insurer and confirm whether Wegovy is on your formulary and what tier it sits on.
- Register for the Wegovy Savings Offer at wegovy.com if you have commercial insurance.
- Compare NovoCare’s oral pill pricing ($149–$299/month) against your injectable out-of-pocket cost before your first fill.
The price floor many commercially insured patients reach with the Wegovy Savings Offer is significantly lower than the list price, which is what you’d pay without any program or coverage at all.
Table of Contents
- What does the Wegovy list price actually mean?
- How does your insurance type change what you pay?
- What are all the ways to lower your monthly Wegovy cost?
- Injectable vs. oral Wegovy: which costs less?
- How to find your exact out-of-pocket cost today
- Why does your monthly cost keep changing?
- Key Takeaways
- What most patients miss when planning their Wegovy costs
- How Glpcare supports patients through the cost and care complexity
- Useful sources for current Wegovy pricing and coverage
- FAQ
What does the Wegovy list price actually mean?
The $1,349 figure is the “wholesale acquisition cost,” essentially a sticker price that manufacturers set and that almost no patient pays directly. Pharmacy benefit managers (PBMs) negotiate rebates with Novo Nordisk behind the scenes, and those rebates flow back to insurers, not to you at the counter. What you pay depends on your plan’s design: your deductible, the formulary tier Wegovy sits on, and whether you qualify for a manufacturer savings program.
| Price Type | Monthly Cost | Notes |
|---|---|---|
| Official list price | $1,349 | Wholesale acquisition cost; rarely what patients pay |
| NovoCare injectable cash | $349 | Self-pay via NovoCare program; dose-dependent |
| NovoCare oral pill (starter) | $149 | Introductory dose; time-limited offer terms apply |
| NovoCare oral pill (maintenance) | Up to $299 | Higher doses priced higher |
| Commercial insurance + Savings Offer | As low as $25 | Eligible commercially insured patients only |
| Medicare GLP-1 Bridge | $50 | Eligible Part D beneficiaries, mid-2026 through end of 2027 |
Prices last checked: June 2026. Always confirm current terms at wegovy.com and novocare.com before your first fill.
One important caveat: NovoCare and Wegovy’s official pages reserve the right to change intro pricing and savings caps at any time. An offer that exists today may look different in three months, especially as you move from a starter dose to a maintenance dose.
Pro Tip: Ask your pharmacist to run a price check using both your insurance and a NovoCare cash price before you decide which route to use. The cheaper option isn’t always the one you’d expect.
How does your insurance type change what you pay?
Insurance type is the single biggest variable in your monthly Wegovy cost. The same prescription can cost $25 or $1,349 depending on your plan, and understanding why helps you push back when coverage is denied.

Commercial insurance
Most commercial plans place Wegovy on a specialty tier, which means coinsurance (a percentage of cost) rather than a flat copay. Before the Wegovy Savings Offer, the coinsurance could be substantial even with coverage. With the savings offer applied, many commercially insured patients can reduce their cost substantially, subject to a maximum savings cap per fill. If your deductible hasn’t been met yet, you’ll pay more in January and February than you will in the back half of the year.
Steps to confirm your commercial coverage:
- Log into your insurer’s member portal and search Wegovy (semaglutide) in the formulary tool
- Register for the Wegovy Savings Offer at wegovy.com to stack the copay card on top of your insurance benefit
Medicare and the GLP-1 Bridge
Traditional Medicare Part D has historically excluded weight-loss drugs. That changed with the Medicare GLP-1 Bridge program, which gives eligible Part D beneficiaries access to all Wegovy doses for a reduced monthly cost from mid-2026 through the end of 2027. Your provider must submit a prior authorization for the covered indication, and CMS eligibility rules apply. Medicare Advantage plans vary: some have added Wegovy coverage independently, so check your specific plan’s formulary.
Manufacturer copay cards, including the Wegovy Savings Offer, cannot be used by Medicare or Medicaid beneficiaries. If you’re on a government program and the Bridge doesn’t apply, ask your provider about Novo Nordisk’s patient assistance program, which has separate income-based eligibility.
Prior authorization: what to expect
Prior authorization can take 1–6 weeks, and first-attempt denials are common. That doesn’t mean you’re out of options.
- Document your BMI (typically 30+ or 27+ with a weight-related condition like hypertension or type 2 diabetes).
- Include records of prior weight-loss attempts (medications, programs, dietary counseling).
- Ask your prescriber to write a letter of medical necessity.
- If denied, request a peer-to-peer review between your doctor and the insurer’s medical reviewer.
Pro Tip: Keep a dated log of every call to your insurer, including the representative’s name and what they told you. That record is your strongest asset if you need to appeal.
What are all the ways to lower your monthly Wegovy cost?
Cost is the primary barrier to starting GLP-1 therapy, and the gap between list price and what you actually pay is wide enough that knowing your options matters more than almost anything else.

Wegovy Savings Offer (commercial insurance only)
The manufacturer’s copay card is the highest-impact tool for commercially insured patients. Enrollment is free at wegovy.com. Once enrolled, the card reduces your cost-share to as little as $25/month, up to a maximum savings amount per fill. Terms changed in early 2026, so verify the current cap before assuming a specific copay level.
Eligibility checklist:
- You have commercial (private) insurance that covers Wegovy
- You are not enrolled in Medicare, Medicaid, or any other federal or state government health program
- You have a valid Wegovy prescription
NovoCare cash pricing
NovoCare is Novo Nordisk’s home delivery pharmacy and offers self-pay pricing tiers that are far below the list price. Current NovoCare pricing runs $149, $199, $299, $349, and $399/month depending on dose and formulation. The oral pill starter dose at $149/month is the lowest branded entry point available.
Enrollment steps:
- Visit novocare.com and select Wegovy.
- Complete the enrollment form with your prescription information.
- Confirm your dose and whether you want the injectable pen or oral tablet.
- Review the current pricing tier for your specific dose before confirming.
Patient assistance programs
For patients who are uninsured or underinsured and meet income thresholds, Novo Nordisk offers a patient assistance program that can provide Wegovy at no cost or reduced cost. Contact NovoCare directly at 1-833-NOVO-411 or visit novocare.com to check eligibility and apply.
Pharmacy discount platforms
GoodRx and similar prescription savings platforms can sometimes reduce the cash price at retail pharmacies, though branded specialty drugs like Wegovy often show limited discounts compared to generics. Always run a GoodRx check at your specific pharmacy before filling, since prices vary by location and chain.
| Savings Route | Who It’s For | Estimated Monthly Cost | Key Restriction |
|---|---|---|---|
| Wegovy Savings Offer | Commercially insured patients | As low as $25 | No government insurance |
| NovoCare injectable cash | Self-pay, any insurance status | ~$349 | Dose-dependent; intro terms vary |
| NovoCare oral pill (starter) | Self-pay, any insurance status | $149–$299 | Time-limited intro pricing |
| Patient assistance program | Uninsured/underinsured, income-qualified | reduced monthly cost | Income and eligibility criteria apply |
| Medicare GLP-1 Bridge | Medicare Part D beneficiaries | $50 | July 2026–Dec 2027 only; PA required |
| GoodRx / pharmacy coupons | Anyone | Varies | Limited impact on branded specialty drugs |
Dos and don’ts:
- Do verify maintenance-dose pricing before you titrate up from a starter dose.
- Do keep receipts and explanation-of-benefits documents for every fill.
- Don’t assume intro pricing continues indefinitely; NovoCare terms can change.
- Don’t use a manufacturer copay card if you’re on Medicare or Medicaid — it’s a federal compliance issue, not just a policy rule.
Injectable vs. oral Wegovy: which costs less?
The FDA-approved oral Wegovy tablet launched in 2026 and meaningfully changed the self-pay math. For patients without insurance coverage or with high cost-sharing, the pill is now the lower-cost branded entry point.

| Formulation | NovoCare Cash (Starter) | NovoCare Cash (Maintenance) | List Price |
|---|---|---|---|
| Weekly injectable pen | $349/month | Higher at max dose | $1,349/month |
| Daily oral tablet | $149/month | Up to $299/month | $1,349/month |
Both formulations carry the same list price, but their cash-pay floors differ significantly. Coverage treatment can also differ: your plan’s formulary may place the injection and the pill on different tiers, or require separate prior authorization for each. Check your specific plan for both.
Practical tradeoffs to consider:
- Adherence: Some patients find a daily pill easier to remember than a weekly injection; others prefer the once-weekly schedule.
- Dose escalation: Both forms follow a titration schedule. As your dose increases, your NovoCare cash price increases with it. The oral pill moves from $149 at the starter dose toward $299 at higher maintenance doses. The injectable moves from $349 upward.
- Side-effect profile: Both contain semaglutide, but absorption differs. Discuss with your clinician which form fits your health profile.
For readers exploring alternatives to weight loss injections, the oral tablet is the most direct branded alternative within the Wegovy line itself.
How to find your exact out-of-pocket cost today
Knowing the ranges is useful. Knowing your number is what lets you plan. Here’s a reproducible checklist.
- Call your insurer. Ask: “Is semaglutide (brand name Wegovy) covered under my plan? What tier is it on? What is my cost-share after my deductible? Is prior authorization required?” Write down the representative’s name and the date.
- Request a pharmacy price estimate. Call your preferred retail pharmacy and ask for a cash price and an insurance price for Wegovy at your prescribed dose. Then check NovoCare’s pricing for the same dose at novocare.com.
- Check GoodRx. Run a search for semaglutide (Wegovy) at your zip code. The discount may be modest for a branded specialty drug, but it takes two minutes and occasionally surprises.
- Enroll in the Wegovy Savings Offer at wegovy.com if you have commercial insurance and meet eligibility criteria. Do this before your first fill, not after.
- Compare retail vs. home delivery. NovoCare’s home delivery pricing is often lower than retail cash pricing. If you’re self-paying, run both numbers side by side.
- Confirm Medicare Bridge eligibility if you have Part D coverage. Ask your provider to submit prior authorization for the covered indication.
Sample script for your insurer call:
If your prior authorization is denied:
- Request the denial in writing with the specific reason.
- Ask your prescriber to submit a letter of medical necessity with your BMI, comorbidities, and prior treatment history.
- Request a peer-to-peer review.
- File a formal appeal. Appeals are frequently successful when supported by clinical documentation.
Pro Tip: Ask your insurer specifically whether your plan allows manufacturer copay cards to be used alongside your benefit. Some plans have “copay accumulator” programs that prevent the card from counting toward your deductible — which changes the math significantly.
Why does your monthly cost keep changing?
Month-to-month Wegovy cost swings are normal, and understanding the drivers helps you budget more accurately.
Deductible timing is the most common cause of sticker shock. If your plan year resets in January, your first one to three fills may hit your deductible at or near list price before insurance kicks in. Once your deductible is met, your cost-share drops to the copay or coinsurance level.
Dose escalation raises cash pricing at every step. Because dose escalation increases monthly cash pricing, patients should verify maintenance-dose costs before titrating off a starter dose. The jump from a starter dose to a full maintenance dose can materially change what you pay, especially on NovoCare’s self-pay tiers.
Formulary tier changes happen at plan renewal. An insurer that covered Wegovy on Tier 3 this year may move it to Tier 4 next year, raising your coinsurance. Review your plan’s formulary each fall during open enrollment.
PBM contracts and rebates shift annually. The rebates Novo Nordisk pays to PBMs affect which plans cover Wegovy and at what tier. This is largely outside your control, but it explains why coverage varies so much between employers even in the same city.
Geographic and pharmacy variation is real. The same prescription can cost $40 more at one chain than another two miles away. Always run a price comparison before committing to a pharmacy.
Budgeting tips for patients starting Wegovy:
- Plan for higher out-of-pocket costs in the first one to three months if your deductible hasn’t been met.
- Re-check NovoCare pricing every time your dose changes.
- Set a calendar reminder to review your plan’s formulary during open enrollment each fall.
- Factor in associated costs: clinician visits (typically every 1–3 months), labs, and any monitoring your provider requires. These add $100–$300/year for most patients on top of medication costs.
A portion of commercially insured patients who enroll in the Wegovy Savings Offer reach the lowest price floor, according to program data cited by price-tracking sources. The remainder pay more due to deductible timing, plan design, or savings cap limits.
Key Takeaways
Wegovy’s list price is high, but the right combination of insurance coverage and manufacturer savings programs can reduce your actual cost significantly.
| Point | Details |
|---|---|
| List price vs. real cost | The $1,349 list price is rarely what patients pay; most reach $25–$349/month through savings programs or NovoCare. |
| Savings Offer power | Commercially insured patients can pay as little as $25/month with the Wegovy Savings Offer; verify current caps before enrolling. |
| Oral pill as a cash option | The oral Wegovy tablet starts at $149/month through NovoCare, making it the lowest-cost branded self-pay option available. |
| Medicare GLP-1 Bridge | Eligible Part D beneficiaries pay $50/month from July 1, 2026 through December 31, 2027; prior authorization required. |
| Glpcare integrated support | Glpcare’s GLP-1 program includes clinician support and enrollment guidance to help patients navigate coverage and savings programs from day one. |
What most patients miss when planning their Wegovy costs
The number I see patients underestimate most isn’t the list price. It’s the maintenance-dose price after the titration period ends.
A patient starts on the oral pill at $149/month through NovoCare, gets comfortable with the cost, and then moves to a higher maintenance dose eight to twelve weeks later. Suddenly the same program costs $249 or $299/month. Nobody warned them. The prescription changed, the dose changed, and the price changed with it, but the savings offer enrollment stayed the same and didn’t automatically adjust. That gap between what they expected to pay and what they actually paid at the pharmacy created real friction, and in some cases, patients skipped fills.
The other common miss is assuming the introductory pricing window is permanent. NovoCare’s time-limited offers are exactly that: time-limited. The $149 starter price exists to lower the barrier to entry, not to lock in your long-term cost. Once you move to maintenance dosing, you’re in a different pricing tier, and the math changes.
What helps is treating Wegovy cost as a moving target rather than a fixed monthly number. Check your price every time your dose changes. Re-verify your savings offer enrollment each plan year. And if you’re on Medicare, confirm your Bridge eligibility before July 1, 2026, because the window is finite.
Glpcare’s integrated approach addresses this directly. Clinician check-ins aren’t just about side effects; they’re also a natural moment to review what you’re paying, whether your savings program is still optimized, and whether a formulation switch makes financial sense. That kind of ongoing support is what separates a prescription from a program.
How Glpcare supports patients through the cost and care complexity
Navigating Wegovy’s pricing tiers, prior authorization timelines, and savings program rules is genuinely complicated, and most patients do it alone. Glpcare is built to change that.

Glpcare’s GLP-1 program includes prescription medication shipped to your home, licensed clinician support, and an AI-driven app that tracks your dose, biometrics, and progress in one place. For cost-conscious patients, the practical difference is this: you get help enrolling in savings programs, guidance through prior authorization paperwork, and a clinician who monitors your dose escalation so you’re never surprised by a price jump at the pharmacy.
The wearable fitness band tracks sleep, heart rate, and activity, giving your care team real data between visits rather than a snapshot every few months. That continuous picture supports better clinical decisions and, often, fewer unnecessary visits.
If you’re ready to see whether you qualify for GLP-1 therapy and want to understand what a supported program would cost you, take the GLP-1 readiness quiz to get started. You can also review Glpcare’s plans and current pricing to compare what’s included at each tier.
Useful sources for current Wegovy pricing and coverage
Prices and program terms change. These are the pages to check first before your next fill or enrollment decision.
- Wegovy official cost and coverage page: Novo Nordisk’s primary page for the Savings Offer, Medicare Bridge details, and eligibility rules. Check here first.
- NovoCare Wegovy pharmacy page: Current cash pricing tiers for injectable and oral formulations, enrollment, and home delivery options.
- NovoCare savings card eligibility: Confirms who qualifies for the copay card and what restrictions apply.
- GLP Chart: Wegovy cost without insurance 2026: Independent price-tracking resource with cash-pay comparisons and annualized cost estimates.
- Drugs.com: How to get Wegovy covered by insurance: Plain-language guidance on prior authorization, formulary tiers, and appeal strategies.
- CMS newsroom: Official CMS announcements on Medicare drug pricing and negotiation updates relevant to GLP-1 coverage.
Article price facts last checked: June 2026. Verify all figures directly with the manufacturer and your insurer before making coverage or payment decisions. This article provides general information, not medical or financial advice. Confirm current program terms and your specific coverage with Novo Nordisk, NovoCare, and your insurance plan.
FAQ
Where is the cheapest place to get Wegovy?
The lowest branded cash price is currently $149/month for the oral starter dose through NovoCare, Novo Nordisk’s home delivery pharmacy. Commercially insured patients using the Wegovy Savings Offer can reach $25/month, and eligible Medicare Part D beneficiaries pay $50/month through the GLP-1 Bridge program (July 2026–December 2027).
How are some people getting Wegovy for $25?
The $25/month price comes from combining commercial insurance coverage with the Wegovy Savings Offer copay card, available at wegovy.com. The card is free to enroll in, but it’s restricted to patients with commercial (private) insurance and cannot be used with Medicare or Medicaid.
What will Wegovy cost at Costco?
Costco pharmacy pricing for Wegovy is not publicly listed in a standardized way and varies by location and membership status. Running a GoodRx check at your local Costco pharmacy before filling is the most reliable way to get a current cash price, though branded specialty drugs like Wegovy typically show limited discounts compared to generics at any retail pharmacy.
Which is cheaper, Ozempic or Wegovy?
Both contain semaglutide and carry similar list prices, but Ozempic is FDA-approved for type 2 diabetes and is more commonly covered by insurance for that indication. Wegovy is approved for weight management. If you’re comparing cash prices, Wegovy’s oral tablet at $149/month through NovoCare is currently the lower-cost branded semaglutide option for self-pay patients focused on weight loss.